mesulergine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (60.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audia, JE; Baez, M; Cohen, ML; Kursar, JD; Lucaites, VL; Nelson, DL; Nissen, JS; Schenck, KW; Wainscott, DB | 1 |
| Mutel, V; Sleight, AJ; Stam, NJ; Vanderheyden, PM | 1 |
| Cleves, AE; Jain, AN; Kirshner, D; Langham, JJ; Spitzer, R | 1 |
| Gorospe, E; Hoffman, BJ; Leonhardt, S; Teitler, M | 1 |
| Dahlgren, IL; Klint, T; Larsson, K | 1 |
| Breeding, M; Sanders-Bush, E | 1 |
| Hietala, J; Kuoppamäki, M; Seppälä, T; Syvälahti, E | 1 |
| Hietala, J; Kuoppamäki, M; Pälvimäki, EP; Syvälahti, E | 1 |
| Choudhary, MS; Craigo, S; Roth, BL | 1 |
| Aulakh, CS; Hulihan-Giblin, BA; Mazzola-Pomietto, P; Murphy, DL | 1 |
| Hietala, J; Kuoppamäki, M; Laakso, A; Pälvimäki, EP; Syvälahti, E | 1 |
| Carey, JE; Chen, C; Elliott, JM; Flanigan, TP; Kumar, C; McDonald, B; Newberry, NR; Newton, RA; Phipps, SL | 1 |
| Conklin, DS; Fitzgerald, LW; Hartig, PR; Iyer, G; Kostich, WA; Krause, CM; Largent, BL; Marshall, AP; Patterson, JP; Tran, DP | 1 |
| Ebersole, BJ; Rosendorff, A; Sealfon, SC | 1 |
| Berg, KA; Clarke, WP; Cropper, JD; Emeson, RB; Niswender, CM; Sanders-Bush, E | 1 |
| Martín-Cora, FJ; Pazos, A | 1 |
| Hietala, J; Majasuo, H; Pälvimäki, EP; Syvälahti, E | 1 |
| Brunden, K; Doucette, C; Graham, E; Hanniford, D; Harrington, J; Poole, MF; Sherf, B; Song, J; Stricker-Krongrad, A; Ting, A | 1 |
| Hietala, J; Laakso, A; Majasuo, H; Pälvimäki, EP; Penttilä, J; Syvälahti, E | 1 |
| Booth, RG; Kondabolu, K; Kuipers, A; Morgan, D; Robertson, KL; Rowland, NE; Sakhuja, R | 1 |
20 other study(ies) available for mesulergine and 4-iodo-2,5-dimethoxyphenylisopropylamine
| Article | Year |
|---|---|
Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
Topics: Animals; Binding Sites; Cell Line; Cloning, Molecular; Gastric Fundus; Inositol 1,4,5-Trisphosphate; Male; Muscle Contraction; Muscle, Smooth; Radioligand Assay; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Temperature | 1993 |
Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.
Topics: 3T3 Cells; Animals; Binding, Competitive; Cell Membrane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Humans; Ketanserin; Mice; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Recombinant Proteins; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1996 |
Physical binding pocket induction for affinity prediction.
Topics: Binding Sites; Ligands; Models, Molecular; Neural Networks, Computer; Peptide Fragments; Protein Binding; Receptor, Serotonin, 5-HT1A | 2009 |
Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
Topics: 3T3 Cells; Amphetamines; Animals; Binding, Competitive; Brain; Cell Membrane; Choroid Plexus; Ergolines; Fibroblasts; GTP-Binding Proteins; Inositol Phosphates; Iodine Radioisotopes; Kinetics; Mice; Neurotransmitter Agents; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Stimulation, Chemical; Swine; Transfection; Tritium | 1992 |
The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior.
Topics: Alprenolol; Amphetamines; Animals; Ergolines; Ketanserin; Male; Piperazines; Rats; Rats, Inbred Strains; Ritanserin; Serotonin Antagonists; Sexual Behavior, Animal | 1992 |
Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Antiparkinson Agents; Cells, Cultured; Choroid Plexus; DOM 2,5-Dimethoxy-4-Methylamphetamine; Epithelial Cells; Ergolines; Hallucinogens; Male; Phosphatidylinositols; Quipazine; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Stereoisomerism | 1991 |
Regulation of serotonin 5-HT2C receptors in the rat choroid plexus after acute clozapine treatment.
Topics: Amphetamines; Animals; Antiparkinson Agents; Autoradiography; Cerebral Cortex; Choroid Plexus; Clozapine; Ergolines; Haloperidol; Image Processing, Computer-Assisted; Injections, Subcutaneous; Male; Neostriatum; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Receptor Agonists | 1994 |
5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine.
Topics: Amphetamines; Animals; Autoradiography; Choroid Plexus; Clozapine; Ergolines; Haloperidol; Hydrolysis; Image Processing, Computer-Assisted; In Vitro Techniques; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Second Messenger Systems; Serotonin Receptor Agonists | 1994 |
A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.
Topics: Amino Acid Sequence; Amphetamines; Animals; Base Sequence; Cell Line, Transformed; Chlorocebus aethiops; Ergolines; Hydrolysis; Ketanserin; Leucine; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylalanine; Phosphatidylinositols; Point Mutation; Radioligand Assay; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP suggests separate mediation by 5-HT2A and 5-HT2C receptors, respectively.
Topics: Amphetamines; Animals; Binding, Competitive; Drug Tolerance; Eating; Ergolines; Frontal Lobe; Injections, Intraperitoneal; Ketanserin; Male; Piperazines; Propane; Radioligand Assay; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Receptor Agonists; Time Factors | 1995 |
Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus.
Topics: Amphetamines; Animals; Antiparkinson Agents; Autoradiography; Choroid Plexus; Citalopram; Ergolines; Fluoxetine; Image Processing, Computer-Assisted; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Up-Regulation | 1996 |
Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
Topics: Adrenergic alpha-Agonists; Amphetamines; Antiparkinson Agents; Calcium; Choroid Plexus; Electrophysiology; Ergolines; Ergotamine; Frontal Lobe; Hallucinogens; Humans; Hydrolysis; Ketanserin; Lysergic Acid Diethylamide; Mescaline; Methoxydimethyltryptamines; Neuroblastoma; Phosphatidylinositols; Piperazines; Quipazine; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Recombinant Proteins; RNA, Messenger; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium; Tumor Cells, Cultured | 1996 |
High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
Topics: Amphetamines; Binding, Competitive; Cell Line; Ergolines; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hydrolysis; Isomerism; Ligands; Models, Biological; Phosphatidylinositols; Receptors, Serotonin; Recombinant Proteins; Serotonin Antagonists; Serotonin Receptor Agonists; Spiperone | 1999 |
Conserved helix 7 tyrosine functions as an activation relay in the serotonin 5HT(2C) receptor.
Topics: Amino Acid Motifs; Amphetamines; Binding, Competitive; Cell Line; Conserved Sequence; Ergolines; Humans; Indoles; Inositol Phosphates; Ligands; Mianserin; Mutation; Protein Structure, Secondary; Pyridines; Quipazine; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection; Tyrosine | 2000 |
RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
Topics: Amphetamines; Animals; Arachidonic Acid; Binding, Competitive; Bufotenin; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Ergolines; Inositol Phosphates; Lysergic Acid Diethylamide; Piperazines; Protein Isoforms; Quipazine; Radioligand Assay; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; RNA Editing; Serotonin; Serotonin Receptor Agonists; Tritium | 2001 |
Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species.
Topics: 5-Methoxytryptamine; Amphetamines; Animals; Autoradiography; Brain; Cerebral Cortex; Corpus Striatum; Ergolines; Guinea Pigs; Humans; Male; Mammals; Radioligand Assay; Radionuclide Imaging; Rats; Rats, Wistar; Receptors, Serotonin; Tritium | 2004 |
Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
Topics: Amphetamines; Animals; Choroid Plexus; Citalopram; Dose-Response Relationship, Drug; Ergolines; Fluoxetine; Hydrolysis; Inositol Phosphates; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Second Messenger Systems; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2005 |
Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Topics: Amphetamines; Binding, Competitive; Calcium Signaling; Cell Line; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ergolines; Humans; Ketanserin; Lysergic Acid Diethylamide; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists; Serotonin Receptor Agonists; Transfection | 2005 |
Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain.
Topics: Amphetamines; Animals; Anti-Anxiety Agents; Antidepressive Agents; Autoradiography; Brain Chemistry; Buspirone; Cerebral Cortex; Choroid Plexus; Citalopram; Ergolines; Hydrolysis; Image Processing, Computer-Assisted; Ketanserin; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin Antagonists | 2006 |
Molecular and behavioral pharmacology of two novel orally-active 5HT2 modulators: potential utility as antipsychotic medications.
Topics: Amphetamines; Animals; Antipsychotic Agents; Cell Line, Transformed; Dose-Response Relationship, Drug; Ergolines; Food Preferences; Glycolates; Head Movements; Humans; Ketanserin; Mice; Mice, Inbred C57BL; Motor Activity; Protein Binding; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium | 2013 |